Download FREE Report Sample
Download Free sampleThe global Fibrinogen market was valued at 617.44 Million USD in 2021 and will grow with a CAGR of 15.48% from 2021 to 2027, based on Research newly published report.
The prime objective of Fibrinogen Market is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, Fibrinogen Market covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer`s products are justly used in local region or countries.The major producers in the industry are CSL Behring, LFB Group and Shanghai RAAS Blood Products, whose revenue ratios in 2019 are 52.52%, 20.36% and 10.02% respectively.
By Market Verdors:
By Types:
By Applications:
Key Indicators Analysed
Key Reasons to Purchase
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy